CNBC Television thumbnail

CNBC Television

Lightning Round: I want you to own D-Wave Quantum, says Jim Cramer

📹 Video Information:

Title: Lightning Round: I want you to own D-Wave Quantum, says Jim Cramer
Duration: 04:36

Overview

This appears to be a transcript from Jim Cramer's "Lightning Round" segment where he quickly answers viewer questions about various stocks. The format involves rapid-fire stock recommendations and brief analysis of different companies brought up by callers from various locations.

Main Topics Covered

  • Stock recommendations
  • Mining companies (Agnico Eagle)
  • Pharmaceutical stocks (Bristol-Myers)
  • Cryptocurrency/fintech companies (Clean Spark)
  • Dividend stocks (Flex LNG)
  • D-Wave (quantum computing)

Key Takeaways & Insights

  • Cramer suggests being selective with stock picks in the current market
  • High dividend yields should be scrutinized for potential underlying issues
  • Some speculative stocks can be worth considering if treated as speculation
  • Market conditions appear to be favorable for certain stocks to make significant moves on positive news

Actionable Strategies

  • Consider Agnico Eagle instead of New Gold for mining exposure
  • Hold Bristol-Myers but monitor their central nervous system drug development
  • Treat Clean Spark as a speculative play only
  • Research thoroughly when encountering unusually high dividend yields

Specific Details & Examples

  • Bristol-Myers described as "never seen it this cheap"
  • Clean Spark mentioned as having 12 analyst buy ratings
  • Flex LNG noted for its 13% dividend yield
  • D-Wave described as capable of 10-point moves on positive news

Warnings & Common Mistakes

  • Caution against assuming high dividends are automatically safe
  • Warning about speculative nature of certain stocks like Clean Spark
  • Need for due diligence when stocks appear unusually cheap

Resources & Next Steps

  • Segment sponsored by Charles Schwab
  • Suggestion to research more deeply into companies with unusually high dividends
  • Importance of following up on specific company developments (like Bristol-Myers' CNS drug)
← Back to CNBC Television Blog